|
Asif's Pakistan career began in 2005 but contains only 11 Tests and 31 ODIs
|
An Indian Premier League (IPL) drugs tribunal has adjourned its hearing on Pakistan paceman Mohammad Asif's drugs appeal without delivering a verdict.
Asif tested positive for the banned steroid nandrolone during the inaugural IPL competition in May last year.
The 26-year-old was banned from all forms of cricket by the Pakistan Cricket Board immediately after the failed test was made public in July.
Earlier this week, Asif asked to be released from his IPL deal.
He was contracted for another season with the Delhi Daredevils.
Asif's 'B' sample was tested and also returned a positive result for the drug.
He was then asked to appear before an IPL drugs panel comprising former India Test captain Sunil Gavaskar, Dr Ravi Bapat and lawyer Shirish Gupte.
An initial hearing was held on 11 October and another was scheduled for 29 November.
That second session was then postponed until 24 January in the aftermath of the attacks in Mumbai.
It remains unclear whether a final decision will be made on Sunday, which was assigned as a reserve day for the hearing, or if the tribunal will fix a fresh date.
Asif, who has played 11 Tests and 31 one-day internationals, faces a two-year ban if his appeal is rejected.
No comments:
Post a Comment